-
281
Molecular biological research and molecular homologous modeling of Bw.03 subgroup
Published 2025-01-01Get full text
Article -
282
Factors That Affect the Sensitivity of Imaging Modalities in Primary Hyperparathyroidism
Published 2021-01-01Get full text
Article -
283
-
284
-
285
-
286
-
287
Potential prebiotic effects of nonabsorptive components of Keemun and Dianhong black tea: an in vitro study
Published 2022-05-01Get full text
Article -
288
-
289
Dysbiosis of Gastric Mucosal Fungal Microbiota in the Gastric Cancer Microenvironment
Published 2022-01-01Get full text
Article -
290
Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
Published 2025-01-01Get full text
Article -
291
Study on Deformation Characteristics of Extended Highway in Operation Period
Published 2022-01-01Get full text
Article -
292
Quantitative determination of the leaching range of in-situ leaching mining area by stagnation point
Published 2025-02-01Get full text
Article -
293
PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
Published 2025-01-01“…Zhaoqian He,1– 3,* Hua Chen,1– 3,* Chen Liang,1– 3,* Xiang Tang,1– 3 Lingmin Jiang,1– 3 Feihu Xie,1– 3 Qi Liu,1– 3 Yun Zheng1– 3 1Department of Liver Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People’s Republic of China; 2Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People’s Republic of China; 3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yun Zheng; Qi Liu, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, People’s Republic of China, Email zhengyun@sysucc.org.cn; liuqi9@sysucc.org.cnPurpose: To compare the clinical outcomes of different systemic therapies, specifically PD(L)1 inhibitors plus Lenvatinib versus Atezolizumab plus Bevacizumab, when combined with hepatic arterial infusion chemotherapy (HAIC) based on the FOLFOX regimen (oxaliplatin, fluorouracil, and leucovorin) as first line treatment for unresectable hepatocellular carcinoma.Patients and Methods: This real-world retrospective study enrolled 294 patients with unresectable HCC. …”
Get full text
Article -
294
-
295
-
296
Towards evaluating and building versatile large language models for medicine
Published 2025-01-01Get full text
Article -
297
-
298
The formation and stripping mechanism of oxide film on stainless steel surfaces
Published 2024-06-01Get full text
Article -
299
-
300